Experimental pill promises new hope for deadly pancreatic cancer

WASHINGTON — A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer. “While not curing the cancer, it is a very large step forward,” said Dr. Zev Wainberg, of the University of California, Los Angeles, who helped lead the study. The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic